Steven M Chaouki has bought stock on 3 days since Aug 2022
President, US Markets at TransUnion, and 1 other company
SEC CIK 0001776865 · Filings on SEC.gov ↗
Steven M Chaouki's record
3 months after each buy, from the first price a copier could get.
3 buys since 2022 with 3 months of prices.
Companies
Every filing
35 filings since Oct 2019, newest first
TransUnion
President, US Markets
TransUnion
President, US Markets
TransUnion
President, US Markets
TransUnion
President, US Markets
TransUnion
President, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Maia Biotechnology, Inc.
Director
Transunion
Pres, US Markets
Maia Biotechnology, Inc.
Director
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Transunion
Pres, US Markets, CI
Maia Biotechnology, Inc.
Director
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
Pres, US Markets
Transunion
EVP - US Markets
Transunion
EVP - US Markets
Transunion
EVP - US Markets
About Steven M Chaouki
Steven M. Chaouki is a Person and serves as President, U.S. Markets and Consumer Interactive at TransUnion, where he oversees two major business lines focused on providing information, insights, credit, financial, and identity protection services to business customers and consumers.( He has held leadership roles at TransUnion since at least 2013, previously serving as Executive Vice President, Financial Services until May 2019, and he joined the company after working at HSBC in card/retail services and auto finance.(
Chaouki earned a bachelor’s degree from Boston University and an M.B.A. from the University of Chicago Booth School of Business.( He also serves on the boards of MAIA Biotechnology, Inc. and Spring Labs, adding board-level governance experience to his operating leadership background.( Recent insider-trading reporting identifies him as a TransUnion executive and notes a 2025 stock sale conducted under a Rule 10b5-1 trading plan.(
Written by Perplexity from public sources.
Filings come from SEC EDGAR. Not investment advice.